Additionally, naringenin might repress glomerular mesangial cells proliferation and ECM accumulation through let-7a/TGFBR1 signaling in DN, and let-7a may be a potential new target for the protection of naringenin against diabetic nephropathy [184]. The gene discussed is TGFBR1; the disease is diabetic kidney disease.